MedPage Today on MSN

For Your Patients: Understanding Your Treatment Options

After stomach cancer is diagnosed, a team of cancer specialists will work together with you to develop a personalized ...

TECVAYLI® monotherapy demonstrates superior progression-free and overall survival versus standard of care as early as first relapse in patients with multiple myeloma ...

Johnson & Johnson (NYSE:JNJ), a worldwide leader in multiple myeloma therapies, today announced positive topline results from the investigational Phase 3 MajesTEC-9 study of TECVAYLI® ...
CURE

Expert Insights: Lunsumio VELO’s Fast Follicular Lymphoma Therapy

Dr. Ian Flinn explains in an interview with CURE how Lunsumio VELO (mosunetuzumab) works and its impact on patients with ...
Archives of Disease in Childhood

Analysis of infectious complications in paediatric autoimmune neutropenia: a French nationwide retrospective cohort study

Background Autoimmune neutropenia (AIN) is the main cause of chronic neutropenia in children, but its infectious consequences ...